These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 13557081)

  • 41. Routine antenatal anti-D prophylaxis and patient compliance with the two-dose regimen.
    Chaffe B; Ford J; Bills V
    Transfus Med; 2007 Oct; 17(5):399-403. PubMed ID: 17903141
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prophylaxis and prenatal treatment of fetal erythroblastosis in pregnancy. A trial of polyvinylpyrrolidone. Preliminary report].
    Fuleston JE; Curto AD; De Dahinten N
    Prensa Med Argent; 1965 Jun; 52(21):1370-1. PubMed ID: 5891784
    [No Abstract]   [Full Text] [Related]  

  • 43. Anti-D in Rh positive pregnancies.
    Prasad MR; Krugh D; Rossi KQ; O'Shaughnessy RW
    Am J Obstet Gynecol; 2006 Oct; 195(4):1158-62. PubMed ID: 17000249
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Contribution of specific immunoglobulin anti-D to prophylaxis of haemolytic disease of the newborn].
    Bianu V; Zervos G; Kondi V; Balan S
    Rev Fr Gynecol Obstet; 1973 Oct; 68(10):569-71. PubMed ID: 17474215
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fetal and neonatal cytopenias: what have we learned?
    Bussel JB
    Am J Perinatol; 2003 Nov; 20(8):425-31. PubMed ID: 14703590
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use of maternal plasma for prenatal RhD blood group genotyping.
    Finning K; Martin P; Daniels G
    Methods Mol Biol; 2009; 496():143-57. PubMed ID: 18839110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Importance of hemolysin tests in prenatal examination].
    SLEPICKA L
    Cesk Pediatr; 1957 Jul; 12(7):623-6. PubMed ID: 13461194
    [No Abstract]   [Full Text] [Related]  

  • 48. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
    Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
    Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immuno-hematological study of 130 married couples examined in the Centro Emodiagnostico of the Guardia Ostetrica Permanente of the city of Naples].
    SANTORO E; PAGNOTTA G; DE LUISE P
    Riv Emoter Immunoematol; 1960; 7():48-50. PubMed ID: 13746379
    [No Abstract]   [Full Text] [Related]  

  • 50. The Rh blood group system in review: a new face for the next decade.
    Westhoff CM
    Transfusion; 2004 Nov; 44(11):1663-73. PubMed ID: 15504174
    [No Abstract]   [Full Text] [Related]  

  • 51. Prenatal determination of the fetal RhD blood group by multiplex PCR: a 7-year Portuguese experience.
    Pereira JC; Couceiro AB; Cunha EM; Machado AI; Tamagnini GP; Martins NP; Ribeiro ML
    Prenat Diagn; 2007 Jul; 27(7):633-7. PubMed ID: 17497744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Is there still an erythroblastosis "problem"?].
    Vivell O; Bickel E; Siebel U
    Therapiewoche; 1965 Aug; 15(16):771-8. PubMed ID: 5893662
    [No Abstract]   [Full Text] [Related]  

  • 53. Prevention of fetal wastage due to erythroblastosis.
    MELNICK A
    J Am Osteopath Assoc; 1957 Apr; 56(8):486-7. PubMed ID: 13416024
    [No Abstract]   [Full Text] [Related]  

  • 54. Prevention of repeat fetal loss in erythroblastosis.
    EVANS TN
    Obstet Gynecol; 1954 Jan; 3(1):80-6. PubMed ID: 13120055
    [No Abstract]   [Full Text] [Related]  

  • 55. [Erythroblastosis--clinical aspects and prevention].
    Eklund J
    Katilolehti; 1968 May; 73(5):233. PubMed ID: 5188093
    [No Abstract]   [Full Text] [Related]  

  • 56. The management of haemolytic disease in pregnancy.
    MEAGHER D
    J Ir Med Assoc; 1957 Apr; 40(238):124-5. PubMed ID: 13416708
    [No Abstract]   [Full Text] [Related]  

  • 57. [The problem of erythroblastosis].
    KAYSER HW
    Med Klin; 1955 Dec; 50(49):2063-5. PubMed ID: 13287791
    [No Abstract]   [Full Text] [Related]  

  • 58. [Prevention of erythroblastosis].
    BERGHOFER F
    Medizinische; 1954 Feb; 7():230-1. PubMed ID: 13153809
    [No Abstract]   [Full Text] [Related]  

  • 59. [Prevention of erythroblastosis].
    KAYSER HW
    Zentralbl Gynakol; 1954; 76(26):1028-32. PubMed ID: 13196611
    [No Abstract]   [Full Text] [Related]  

  • 60. Erythroblastosis fetalis-obstetrical aspects.
    MORLEY GW
    Med Bull (Ann Arbor); 1957 Sep; 23(9):310-4. PubMed ID: 13486667
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.